Litcius/Paper detail

NLRP3 and pyroptosis blockers for treating inflammatory diseases

Rebecca C. Coll, Kate Schroder, Pablo Pelegrı́n

2022Trends in Pharmacological Sciences747 citationsDOIOpen Access PDF

Abstract

functions in concert with the NLR family, caspase activation and recruitment domain (CARD)containing 4 (NLRC4); (v) absent in melanoma 2 (AIM2); and (vi) Pyrin (PYD) These inflammasome sensor proteins recognize distinct perturbations of homeostasis and form oligomers able to recruit the adaptor protein apoptosis-associated speck-like protein containing a CARD (ASC) into the Glossary Cryopyrin-associated periodic syndromes (CAPS): rare autoinflammatory disorders resulting from gain-of-function mutations in NLRP3 and characterized by periodic fevers, sterile urticaria, and joint inflammation. CAPS incorporate three overlapping disease entities: familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal-onset multisystem autoinflammatory syndrome (NOMID). Gasdermin D (GSDMD): pore-forming protein that induces pyroptosis downstream of inflammasome activation. Inflammasome: signaling complex that activates inflammatory caspases. Most inflammasomes are multiprotein assemblies that activate the caspase-1 protease. The so-called 'non-canonical inflammasome' is a protein-lipid assembly that activates the protease function of caspase-11 in mice and caspase-4 and caspase-5 in humans.

Topics & Concepts

PyroptosisMedicineInflammationNeurosciencePharmacologyPsychologyImmunologyInflammasomeInflammasome and immune disordersGout, Hyperuricemia, Uric AcidHeme Oxygenase-1 and Carbon Monoxide
NLRP3 and pyroptosis blockers for treating inflammatory diseases | Litcius